Which region is lucrative for the primary cells market?

 

The global primary cells market size is projected to reach USD 1,613 million by 2025 from USD 970 million in 2020, at a CAGR of 10.7% during the forecast period. North America accounted for the largest share in the primary cells market. The growth in the North American primary cells market can be attributed to the increasing number of players launching new human primary cells for research, expansion of the pharmaceutical and biotechnology industries, growing focus on R&D, and increasing prevalence of cancer in the region.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=32854960

Growth in the primary cells market is mainly driven by factors such as increasing cancer research, the advantages of primary human cells over cell lines, the increasing demand for monoclonal antibodies, rapid growth in the biotechnology & biopharmaceutical industries, and growing focus on personalized medicine.

Biomedical research using primary cells in 3D cultures is also expected to provide a wide range of growth opportunities for players in the market. On the other hand, concerns regarding primary cell culture contamination are expected to limit market growth to a certain extent in the coming years.

North America is the largest regional market for primary cells market

The primary cells market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW).

Get 10% Free Customization on this Report @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=32854960

This report categorizes the primary cells market into the following segments and subsegments:

By Origin

·         Human Primary Cells

·         Animal Primary Cells

By Type

·         Hematopoietic Cells

·         Dermatocytes

·         Gastrointestinal Cells

·         Hepatocytes

·         Lung Cells

·         Renal Cells

·         Heart Cells

·         Musculoskeletal Cells

·         Other Primary Cells

By End User

·         Life Science Research Companies

·         Research Institutes

By Region

·         North America

·         Europe

·         Asia Pacific

·         China

·         Japan

·         Rest of Asia Pacific

·         Rest of the World

Recent Developments

·         BioIVT (US) introduced high-purity Kupffer cells to its portfolio of human primary hepatic cells to support liver disease drug discovery and development.

·         Charles River Laboratories acquired HemaCare Corporation. This acquisition will aid in expanding Charles River’s scientific capabilities in the high-growth cell therapy sector.

·         Sekisui XenoTech, LLC. (US) added monkey and rodent hepatocytes to its patented CryostaX product line.

Frequently Asked Questions (FAQ):

·         What are the recent trends affecting the primary cells market?

·         What are the different types of primary cells used?

·         Who are the key players in the primary cells market?

·         Who are the key end-users of the primary cells market?

 

Request for Sample Pages @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=32854960